[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market",
    "summary": "Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=774959710460b9c977fc9c5dfd244abefedbf9e5a61d4c68a1417f282469a4b8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744216560,
      "headline": "Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market",
      "id": 133848575,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=774959710460b9c977fc9c5dfd244abefedbf9e5a61d4c68a1417f282469a4b8"
    }
  },
  {
    "ts": null,
    "headline": "5 Top Growth Stocks to Buy in the Stock Market Sell-Off",
    "summary": "Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right now -- quite the contrary.  History tells us that equities tend to experience strong runs following downturns, so it's worth putting money into excellent companies that are being dragged down with along with the broader market.  To that end, let's consider five excellent growth-oriented companies to invest in on the dip: Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), Vertex Pharmaceuticals (NASDAQ: VRTX), Intuitive Surgical (NASDAQ: ISRG), and Shopify (NASDAQ: SHOP).",
    "url": "https://finnhub.io/api/news?id=e2ae07b456f7d441e163f9ffa83e82d935c906f5a457afd4cda51092bf90c836",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744207200,
      "headline": "5 Top Growth Stocks to Buy in the Stock Market Sell-Off",
      "id": 133828252,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right now -- quite the contrary.  History tells us that equities tend to experience strong runs following downturns, so it's worth putting money into excellent companies that are being dragged down with along with the broader market.  To that end, let's consider five excellent growth-oriented companies to invest in on the dip: Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), Vertex Pharmaceuticals (NASDAQ: VRTX), Intuitive Surgical (NASDAQ: ISRG), and Shopify (NASDAQ: SHOP).",
      "url": "https://finnhub.io/api/news?id=e2ae07b456f7d441e163f9ffa83e82d935c906f5a457afd4cda51092bf90c836"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know",
    "summary": "Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=cea947c0430fc8ebe7c0ce1f9bdd4778ea118e967f2708c96248b357066a7812",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744203609,
      "headline": "Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know",
      "id": 133844453,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=cea947c0430fc8ebe7c0ce1f9bdd4778ea118e967f2708c96248b357066a7812"
    }
  },
  {
    "ts": null,
    "headline": "An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued",
    "summary": "Key Insights Vertex Pharmaceuticals' estimated fair value is US$797 based on 2 Stage Free Cash Flow to Equity Current...",
    "url": "https://finnhub.io/api/news?id=056a402f81486dd8a8dbd9cc73afa6641c92f304c95167825878b3380060134e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744196414,
      "headline": "An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued",
      "id": 133828487,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Key Insights Vertex Pharmaceuticals' estimated fair value is US$797 based on 2 Stage Free Cash Flow to Equity Current...",
      "url": "https://finnhub.io/api/news?id=056a402f81486dd8a8dbd9cc73afa6641c92f304c95167825878b3380060134e"
    }
  },
  {
    "ts": null,
    "headline": "GreensKeeper Value Fund Q1 2025 Letter",
    "summary": "GreensKeeper Value Fund Q1 2025 Letter",
    "url": "https://finnhub.io/api/news?id=3b5d93b9313362aa121b1ac577ad0ff907370506b223d0c9211740c1dd272172",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744182600,
      "headline": "GreensKeeper Value Fund Q1 2025 Letter",
      "id": 133826924,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=3b5d93b9313362aa121b1ac577ad0ff907370506b223d0c9211740c1dd272172"
    }
  }
]